Stefan Niewiesk
Ohio State University
139 Papers
1K Citations
Stefan Niewiesk is an academic researcher from Ohio State University. The author has contributed to research in topics: Virus & Measles virus. The author has an hindex of 35, co-authored 128 publications. Previous affiliations of Stefan Niewiesk include The Research Institute at Nationwide Children's Hospital & University of California, Davis.
Chat about Author
Papers
Mathematical Modeling Identifies the Role of Adaptive Immunity as a Key Controller of Respiratory Syncytial Virus (RSV) Titer in Cotton Rats
Darren Wethington,Olivia Harder,Karthik Uppulury,William C. L. Stewart,William C. L. Stewart,Phylip Chen,Phylip Chen,Tiffany King,Tiffany King,Susan D. Reynolds,Susan D. Reynolds,Mark E. Peeples,Mark E. Peeples,Stefan Niewiesk,Jayajit Das +14 more
TL;DR: A mechanistic computational model with predictive powers for describing RSV infection kinetics in cotton rats was constructed synergistically with in vitro and in vivo measurements and determined an important role for CD8+ T cells responses in reducing RSV titers in Cotton rats.
Inhibition of Vaccine Responses by Maternal Antibodies
TL;DR: Asi sonrasi serokonversiyonun maternal antikorlarla inhibisyonu insan ve veteriner hekimliginde siklikla gozlenen bir olaydir, en iyi dokumante edilmis orneklerinden biri kizamik asilamasidir gan hucre yaniti, tip I interferon, beyaz fare (cotton rat).
1
Faculty Turnover: It's Preventable
TL;DR: In this paper , Niewiesk and Garrity-Rokous proposed a programmatic approach to departmental leadership that address faculty turnover proactively, using the academic leadership framework to scaffold such an approach.
1
Measles VirusNucleocapsid Protein Protects RatsfromEncephalitis
Bettina Bankamp,Andrea Reich,Stefan Niewiesk,Volker ter Meulen +3 more
- 01 Jan 1991
TL;DR: Results indicate that a CD4+cell-mediated immuneresponsespecific for theN protein ofmeasles virus issufficient tocontrol measles virus infections of thecentral nervous system, and that overcomingacutemeasles requires a competentCMI systemtoclear theMV infection.
Patent
Vaccines and methods of making and using vaccines for prevention of respiratory syncytial virus (rsv) infections
Stefan Niewiesk,Basavaraj Binjawadagi,Li Jianrong,Mark E. Peeples +3 more
- 03 Sep 2020
TL;DR: In this paper, vaccines, immunogenic compositions, and methods of using the same to treat and prevent respiratory syncytial virus (RSV) were discussed, where a protein or immunogenic fragment of RSV is delivered to a subject in a recombinant viral vector platform, such as vesicular stomatis virus (rVSV).